Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

The AstraZeneca and GSK share prices look like buys to me as the FTSE 100 crashes

| Harvey Jones

Harvey Jones says AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) have the antidote to the current FTSE 100…

Read more »

Investing Articles

I think this FTSE 100 dividend stock could be poised for big gains in 2019

| Royston Wild

Royston Wild identifies a FTSE 100 (INDEXFTSE: UKX) income hero that could sprint still higher in 2019.

Read more »

Investing Articles

The AstraZeneca share price has smashed the FTSE 100 in 2018. I say it could do so again in 2019

| Rupert Hargreaves

Rupert Hargreaves explains why he thinks AstraZeneca plc (LON:AZN) will continue to outperform the FTSE 100 (INDEXFTSE: UKX).

Read more »

Investing Articles

Why I think AstraZeneca should be in your 2019 share portfolio

| Tezcan Gecgil, PhD

AstraZeneca plc (LON: AZN) has multiple positive catalysts and I see a buying opportunity right now.

Read more »

Investing Articles

3 FTSE 100 shares I think are better than a buy-to-let property

| Andy Ross

If you're thinking of investing in buy-to-let, these three stocks could be a better buy, says Andy Ross.

Read more »

Investing Articles

Could AstraZeneca boost your retirement income as the State Pension age rises?

| Peter Stephens

Could AstraZeneca plc’s (LON: AZN) dividend prospects help to offset the challenges posed by the State Pension?

Read more »

Investing Articles

Forget 1.5% from a cash ISA. FTSE 100 member AstraZeneca is up by 20% in 2018

| Roland Head

Roland Head asks whether FTSE 100 (INDEXFTSE:UKX) dividend stock AstraZeneca plc (LON:AZN) deserves a buy rating.

Read more »

Investing Articles

Don’t panic! How I think you can Brexit-proof your shares portfolio with these FTSE 100 dividend stocks

| Royston Wild

If you're worried about Brexit, then I think shopping for these FTSE 100 (INDEXFTSE: UKX) dividend stocks should be at…

Read more »

Investing Articles

Can the AstraZeneca share price continue to smash the FTSE 100?

| G A Chester

G A Chester discusses the valuation and prospects of FTSE 100 (INDEXFTSE:UKX) pharma stock AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

Is the wait finally over for the AstraZeneca share price?

| Alan Oscroft

Investors have waited patiently for AstraZeneca plc (LON: AZN) to get back to earnings growth. I don't think there's much…

Read more »

Investing Articles

Have £1,000 to invest? Why I’d buy FTSE 100-member AstraZeneca over a cash ISA

| Peter Stephens

AstraZeneca plc (LON:AZN) could offer stronger growth potential than the FTSE 100 (INDEXFTSE:UKX) or a cash ISA.

Read more »

Investing Articles

Should I pile into Lloyds or AstraZeneca in this volatile market?

| Kevin Godbold

Lloyds Banking Group plc (LON: LLOY) and AstraZeneca plc (LON: AZN) are very different beasts. Here’s which one I’d choose.

Read more »